Blood‑brain barrier dysfunction in schizophrenia: Mechanisms and implications (Review).
1Department of Psychiatry, The Psychiatric Hospital of Guangzhou Civil Administration Bureau, Guangzhou, Guangdong 510430, P.R. China.
International Journal of Molecular Medicine
|July 25, 2025
Summary
Blood-brain barrier (BBB) dysfunction is increasingly linked to schizophrenia development and worsening. Targeting the BBB may offer new therapeutic strategies for schizophrenia, improving treatment effectiveness.
Area of Science:
- Neuroscience
- Psychiatry
- Biomedical Science
Background:
- Schizophrenia is a complex psychiatric disorder with a significant unmet need for effective treatments.
- Emerging evidence suggests a critical role for the blood-brain barrier (BBB) in schizophrenia pathophysiology.
Purpose of the Study:
- To review and integrate current findings on the role of BBB dysfunction in schizophrenia.
- To explore the mechanisms linking BBB dysfunction to schizophrenia.
- To discuss potential BBB-targeted therapeutic interventions.
Main Methods:
- Comprehensive literature review integrating data from biochemical markers, neuroimaging, genetic studies, and experimental models.
- Analysis of mechanisms including cerebral blood flow, neuroinflammation, and neurotransmitter systems.
- Discussion of therapeutic strategies and clinical implications.
Main Results:
- BBB dysfunction is implicated in the development and progression of schizophrenia.
- Mechanisms include disrupted cerebral blood flow, enhanced neuroinflammation, and altered neurotransmitter systems.
- BBB dysfunction contributes to schizophrenia pathophysiology.
Conclusions:
- BBB dysfunction is a significant factor in schizophrenia.
- Targeting the BBB presents a promising avenue for novel therapeutic strategies.
- BBB-targeted interventions could improve drug efficacy and reduce side effects in schizophrenia treatment.
Keywords:
blood‑brain barrier integrityneuroin‑flammationneurophysiological mechanismspsychiatric neuroimagingschizophreniatherapeutic innovationsMore Related Videos
Related Concept Videos
The Blood-brain Barrier
48.8K
Overview
48.8K
Biological Causes of Schizophrenia
149
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
149
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
967
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
967
Psychological and Sociocultural Causes of Schizophrenia
189
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
189
Schizophrenia
226
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
226
Factors Affecting Drug Distribution: Physiological Barriers
332
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
332


